Australia markets open in 3 hours 31 minutes

Bellerophon Therapeutics, Inc. (BLPH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.06250.0000 (0.00%)
At close: 01:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-19,087
-19,831
-17,756
-24,728
Depreciation & amortisation
82
65
102
147
Stock-based compensation
724
786
1,126
1,633
Change in working capital
885
1,211
-5,693
2,437
Accounts payable
325
825
-5,493
2,452
Other working capital
-17,396
-17,770
-22,821
-19,884
Other non-cash items
-
-
-
300
Net cash provided by operating activities
-17,396
-17,770
-22,821
-19,884
Cash flows from investing activities
Sales/maturities of investments
-
-
-
0
Net cash used for investing activities
-
-
-
0
Cash flows from financing activities
Common stock issued
1,437
0
0
54,696
Common stock repurchased
-
-
-
0
Other financing activities
-
-40
-
-186
Net cash used provided by (used for) financing activities
4,968
-40
0
57,567
Net change in cash
-17,396
-17,810
-22,821
37,683
Cash at beginning of period
29,117
25,139
47,960
10,277
Cash at end of period
11,721
7,329
25,139
47,960
Free cash flow
Operating cash flow
-17,396
-17,770
-22,821
-19,884
Free cash flow
-17,396
-17,770
-22,821
-19,884